Intracecally administered insulin in chronically diabetic pigs

Current Therapeutic Research - Clinical and Experimental

Volumn 58, Issue 1, 1997, Pages 16-25

  Elias, Alan N ^a,d   Gordon, Ian L ^a   Porzio, Robert ^b   Willis, M Lynn ^b   Pandian, M Raj ^c   Gwinup, Grant ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diabetes; methacrylic copolymer; oral insulin; pig

Indexed keywords

APROTININ; CHOLESTEROL; COPOLYMER; DODECYL SULFATE SODIUM; GELUCIRE 44-14; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HUMAN INSULIN; LOW DENSITY LIPOPROTEIN; METHACRYLIC ACID; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CATHETER; CECUM; CONTROLLED STUDY; ENCAPSULATION; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE;

EID: 0031028623     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(97)80073-2     Document Type: Article

References (30)

1. Stolar MW. Atherosclerosis in diabetes: The role of hyperinsulinemia. Metabolism. 1988; 37:1-9.
2. Dupre J, Behme MT, Hramick IM, Lomgo CJ. Hepatic extraction of insulin after stimulation of secretion with oral glucose and parenteral nutrition. Metabolism. 1993;42:921-927.
3. Osei K, Schuster DP. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabetic Med. 1994;11:755-762.
4. Duff GL, Brechin DJH, Finkelstein WE. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. J Exp Med. 1954;100:371-380.
5. Gertler MM, Leetma HE, Saluste E. Ischaemic heart disease: Insulin, carbohydrate and lipid interrelationships. Circulation. 1972;46:103-111.
6. Rubenstein AH, Seftal HC, Miller K, et al. Metabolic responses to oral glucose in healthy South African white, Indian and African subjects. BMJ. 1969;1:748-751.
7. Sloan JM, Mackay JS, Sheridan B. The incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic disease. Diabetologia. 1971;7: 431-433.
8. dos Reis RM, Foss MC, Moura MD, et al. Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism. Gynecol Endocrinol. 1995;9:45-50.
9. Nahum R, Thong KJ, Hillier SG. Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod. 1995;10:75-81.
10. Sutterlin M, Steck T. Sensitivity of plasma insulin levels in obese and non-obese women with functional hyperandrogenism. Gynecol Endocrinol. 1995;9:37-44.
11. Lahtela JT, Mustonen J, Pasternak A. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment. Clin Sci. 1995;88:427-432.
12. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995; 75:473-486.
13. Zavorini I, Bonini L, Fantuzzi M, et al. Hyperinsulinemia, obesity and syndrome X. J Intern Med. 1994;235:51-56.
14. Jarret RJ. Is insulin atherogenic? Diabetologia. 1988;31:71-75.
15. Bierman EL. Atherogenesis in diabetes. Arterioscler Thrombo. 1992;12:647-659.
16. Stout RW. The effect of insulin and glucose on sterol synthesis in cultured human skin fibroblasts: Mechanism of insulin-induced stimulation. Athrosclerosis. 1977;27:271-278.
17. Chait A, Bierman EL, Albers JJ. Low density lipoprotein receptor activity in cultured human skin fibroblasts: Mechanism of insulin-induced stimulation. J Clin Invest. 1979; 64:1309-1319.
18. Young JR, Stout RW. Effects of insulin and glucose on the cells of the arterial wall: Interaction of insulin and bibutyryl cyclic AMP and low density lipoprotein on arterial cells. Diabetes Metab. 1987;13:301-306.
19. Oppenheimer MJ, Sundquist K, Bierman EL. Downregulation of high density lipoprotein receptor activity in human fibroblasts by insulin and IGF-I. Diabetes. 1989;38:117-122.
20. Brazg RL, Bierman EL. Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured skin fibroblasts. Diabetologia. 1993;36:942-947.
21. Fujiwara R, Shimada A, Tamai T, et al. Effects of insulin, insulin-like growth factor-I, and phorbol esters on neutral cholesteryl esterase activity in cultured rat vascular smooth muscle cells. J Lab Clin Med. 1995;126:240-246.
22. Lanza RP, Kuhtreiber W, Ecker D, et al. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation. 1995;59:1377-1384.
23. Scharp DW, Swanson CJ, Olack BJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I and type II diabetes and in nondiabetic subjects. Diabetes. 1994;43:1167-1170.
24. Carroll PB, Rilo HL, Alejandro R, et al. Long term (>3 yr) insulin independence in a patient with pancreatic islet cell transplantation following upper abdominal exenteration and liver replacement for fibrolamellar hepatocellular carcinoma. Transplantation. 1995; 59:875-879.
25. Rastellini C, Carroll PB, Rilo HR, et al. Baboon pancreatic islet isolation and transplantation. Transplant Proc. 1994;26:3428-3429.
26. Gwinup G, Elias AN, Domurat ES. Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen Pharmacol. 1991;22:243-246.
27. Elias AN, Gordon I, Vaziri ND, et al. Effective portal insulin delivery with enzyme-protected capsules in pancreatectomized pigs. Gen Pharmacol. 1992;23:55-59.
28. Sperling MA. Control of insulin secretion. Symposium on new development in diabetes. Calif Med. 1973;119:17-22.
29. Hossein M, Abramowitz W, Watrous BJ, et al. Gastrointestinal transit of nondisintegrating nonerodible oral dosage forms in pigs. Pharm Res. 1990;7:1163-1166.
30. Porzio R, Elias AN, Gordon IL, et al. Kinetics of enteric-coated barium capsule dissolution in swine colon. In press.